Page last updated: 2024-09-05

erlotinib hydrochloride and Hematoma, Subdural

erlotinib hydrochloride has been researched along with Hematoma, Subdural in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, MY; Huang, YJ; Liu, SF; Wang, CJ	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Hematoma, Subdural

Article	Year
Exacerbated radiodermatitis and bilateral subdural hemorrhage after whole brain irradiation combined with epidermal growth factor receptor tyrosine kinase inhibitors for brain metastases in lung cancer. Lung cancer (Amsterdam, Netherlands), 2008, Volume: 59, Issue:3 Topics: Brain Neoplasms; Erlotinib Hydrochloride; Fatal Outcome; Hematoma, Subdural; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Radiodermatitis	2008

Article

Year

Exacerbated radiodermatitis and bilateral subdural hemorrhage after whole brain irradiation combined with epidermal growth factor receptor tyrosine kinase inhibitors for brain metastases in lung cancer.

Lung cancer (Amsterdam, Netherlands), 2008, Volume: 59, Issue:3

Topics: Brain Neoplasms; Erlotinib Hydrochloride; Fatal Outcome; Hematoma, Subdural; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Radiodermatitis

2008